Deborah Sweet
Allergy & Immunology · Colorado Springs, CONPI 1184818478
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 35.6% of the total. That places this record below the midpoint for allergy & immunology clinicians in CO, where the typical reported total is $2,675.
Across 121 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$981
- Takeda Pharmaceuticals U.S.A., Inc.$470
- Regeneron Healthcare Solutions, Inc.$186
- Genentech USA, Inc.$173
- Grifols USA, LLC$172
- GSK$141
- plus $634 from 15 others
What the payments were for
- Food & beverage$2,756100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $981 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $470 |
| Regeneron Healthcare Solutions, Inc. | 10 | $186 |
| Genentech USA, Inc. | 7 | $173 |
| Grifols USA, LLC | 7 | $172 |
| GSK | 7 | $141 |
| Kaleo, Inc. | 4 | $95 |
| Sanofi | 5 | $94 |
| Novartis | 4 | $71 |
| Biocryst US Sales Co., LLC | 3 | $69 |
| CSL Behring | 2 | $66 |
| Amgen | 2 | $37 |
| Pfizer | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Optinose US, Inc. | 1 | $25 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| QOL Medical, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$130
How this compares
$2,756 in reported general payments places this provider in the 50th percentile of 89 allergy & immunology providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $21,460 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $9,591 |
| Spiriva RespimatTiotropium Bromide | 13 | $7,737 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $6,645 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $3,265 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $1,782 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $814 |
| Azelastine Hcl | 13 | $547 |
| Ipratropium Bromide | 11 | $396 |
| Montelukast Sodium | 24 | $276 |
| Fluticasone Propionate | 21 | $212 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $141 | $31,05040 claims |
| Boehringer IngelheimSpiriva Respimat | $16 | $7,73713 claims |
| AstraZenecaSymbicort | $981 | $6,64520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 89 allergy & immunology providers in Colorado.
Other allergy & immunology in Colorado Springs
- Christopher WebberColorado Springs$350K
- Eric CaplanColorado Springs$290K
- Robert NathanColorado Springs$130K
- Jill HansonColorado Springs$15K
- Sterling KosmachColorado Springs$7K
- Rohit KatialDenver$758K
- Nicole BarberisLakewood$351K
- Jeffrey RumbyrtLakewood$348K
- Eileen WangDenver$274K
- Donald LeungDenver$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.